/PRNewswire/ The neuromodulation market is projected to progress at a CAGR of 12.02 % between 2022 and 2027, the size of the market is forecast to increase.
/PRNewswire/ Evren Technologies, an innovator in the field of medical neuromodulation devices, today announced the launch of its pioneering Phoenix® 100.
/PRNewswire/ Evren Technologies, Inc., developer of the post-traumatic stress disorder (PTSD) treatment solution that recently received Breakthrough Device.